63187-0256 Ondansetron

Product NDC:

63187-0256

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 63187-0256-20

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-20)

Effective Date: June 1, 2017

Discontinued:

Code: 63187-0256-30

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-30)

Effective Date: June 1, 2017

Discontinued:

Code: 63187-0256-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-05)

Effective Date: Dec. 28, 2022

Discontinued:

Code: 63187-0256-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-10)

Effective Date: Dec. 28, 2022

Discontinued:

Code: 63187-0256-15

Description: 15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-15)

Effective Date: Dec. 28, 2022

Discontinued:

Code: 63187-0256-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-06)

Effective Date: Jan. 24, 2024

Discontinued:

Code: 63187-0256-12

Description: 12 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-12)

Effective Date: March 26, 2024

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC